Contatto
Come acquistare
Consegna
Guida all'acquisto
Inglese
372 b
30 giorni per il reso
I clienti hanno acquistato anche
/
In brossura
9.29
€
Gemcitabine was synthesised in the 1980s at Lilly Research Laboratories (Eli Lilly and Co., Indianapolis, IN). It was initially developed as an antiviral agent, but it had an extremely narrow therapeutic index due to its cytotoxicity against the parental cell lines. As it presented wide activity against various solid tumors it was then evaluated as an anticancer drug. This pyrimidine antimetabolite was firstly approved in 1996 by the Food and Drug Administration (FDA) for the treatment of pancreatic cancer. It is currently used for the treatment of many other malignancies such as lung cancer, breast cancer, lymphoma, bladder cancer, mesothelioma and ovarian cancer. This book discusses the molecular pharmacology, and the pharmacogenetics of gemcitabine. It also discusses the antineoplastic mechanism of gemcitabine on tumour cells; the systemic adverse effects; and provides detail on the clinical uses gemcitabine has on breast cancer.
Informazioni sul libro
Inglese
Regala questo libro oggi stesso
È facile
1 Aggiungi il libro al carrello e scegli la consegna come regalo 2 Ti invieremo subito il buono 3 Il libro arriverà all'indirizzo del destinatarioPotrebbe interessarti anche
/
In brossura
17.39
€
/
In brossura
29.69
€
/
In brossura
5.79
€
/
In brossura
89.89
€
/
In brossura
13.49
€
Ciao! Sono Libroamiko, il tuo consulente di libri.
Come posso aiutarti?